InventisBio

About:

InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.

Website: http://www.inventisbio.com/

Top Investors: Qiming Venture Partners, Matrix Partners China, OrbiMed, Lilly Asia Ventures, GL Ventures LLC

Description:

InventisBio is a biotech company whose product pipeline includes small molecule drug candidates for targeted therapies in lung cancer, breast cancer and gout. The company is also actively developing drugs that can be combined with other immune-oncology targeted therapies, such as PD-1 antibody, for various cancer indications. The company is co-founded by Dr. Yaolin Wang and other scientists who have previously worked at Merck and Schering-Plough, leading various drug discovery projects in oncology, metabolic and infectious disease areas.